Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christiane Gasperi

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Brain Communications|September 11, 2025
Replication of the 2023 radiologically isolated syndrome criteria in a multi-centre cohortFriederike Held, Paula Uibel, Cornelius Berberich, et al.
Therapeutic Advances in Musculoskeletal Disease|May 19, 2022
Ultrasound-detected inflammation is more common in clinically manifest hand osteoarthritis than in painless bony enlarged finger joints: subanalysis of the population-based Bruneck studyNina Gasperi, Nikolaus Schreiber, Philipp Bosch, et al.
Neuroimage. Clinical|January 9, 2023
Lesion location across diagnostic regions in multiple sclerosisViola Pongratz, Matthias Bussas, Paul Schmidt, et al.
Cell|February 26, 2026
Large-scale proteomics across neurological disorders uncovers biomarker panel and targets in multiple sclerosisJakob Maximilian Bader, Christine Makarov, Sabrina Richter, et al.
JAMA Neurology|April 30, 2019
Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple SclerosisChristiane Gasperi, Anke Salmen, Gisela Antony, et al.
Therapeutic Advances in Neurological Disorders|March 30, 2023
Retrospective cohort study to devise a treatment decision score predicting adverse 24-month radiological activity in early multiple sclerosisAlexander Hapfelmeier, Begum Irmak On, Mark Mühlau, et al.
BMC Medicine|November 4, 2020
Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWASTill F M Andlauer, Jenny Link, Dorothea Martin, et al.
Nature Genetics|May 13, 2024
Genetic mapping across autoimmune diseases reveals shared associations and mechanismsMatthew R Lincoln, Noah Connally, Pierre-Paul Axisa, et al.
Journal of Neurology|May 27, 2025
Correction: Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association studyFerdinando Clarelli, Andrea Corona, Kimmo Pääkkönen, et al.
Nature Immunology|November 29, 2016
Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic T<sub>H</sub>17 cellsSylvia Heink, Nir Yogev, Christoph Garbers, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Brain Communications|September 11, 2025
Replication of the 2023 radiologically isolated syndrome criteria in a multi-centre cohortFriederike Held, Paula Uibel, Cornelius Berberich, et al.
Therapeutic Advances in Musculoskeletal Disease|May 19, 2022
Ultrasound-detected inflammation is more common in clinically manifest hand osteoarthritis than in painless bony enlarged finger joints: subanalysis of the population-based Bruneck studyNina Gasperi, Nikolaus Schreiber, Philipp Bosch, et al.
Neuroimage. Clinical|January 9, 2023
Lesion location across diagnostic regions in multiple sclerosisViola Pongratz, Matthias Bussas, Paul Schmidt, et al.
Cell|February 26, 2026
Large-scale proteomics across neurological disorders uncovers biomarker panel and targets in multiple sclerosisJakob Maximilian Bader, Christine Makarov, Sabrina Richter, et al.
JAMA Neurology|April 30, 2019
Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple SclerosisChristiane Gasperi, Anke Salmen, Gisela Antony, et al.
Therapeutic Advances in Neurological Disorders|March 30, 2023
Retrospective cohort study to devise a treatment decision score predicting adverse 24-month radiological activity in early multiple sclerosisAlexander Hapfelmeier, Begum Irmak On, Mark Mühlau, et al.
BMC Medicine|November 4, 2020
Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWASTill F M Andlauer, Jenny Link, Dorothea Martin, et al.
Nature Genetics|May 13, 2024
Genetic mapping across autoimmune diseases reveals shared associations and mechanismsMatthew R Lincoln, Noah Connally, Pierre-Paul Axisa, et al.
Journal of Neurology|May 27, 2025
Correction: Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association studyFerdinando Clarelli, Andrea Corona, Kimmo Pääkkönen, et al.
Nature Immunology|November 29, 2016
Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic T<sub>H</sub>17 cellsSylvia Heink, Nir Yogev, Christoph Garbers, et al.
Pageof 4